Riskpilot← Back to searchSign inGet full accessTerapiamerkurius Oy
OYActiveY-tunnus 2519458-5Puntalantie 2Other human health activities n.e.c. · NACE 8699Est. 201229 employeeswww.terapiakeskuspuro.com
Revenue 2024
EUR 2,3M
-1% vs 2023
EBITDA margin
9.3%
+103% vs 2023
Equity ratio
66.3%
Financial strength
Net profit 2024
EUR 155K
+146% vs 2023
| Revenue | EUR 2,3M | -1% |
| EBITDA | EUR 210K | +103% |
| Net profit | EUR 155K | +146% |
| Total assets | EUR 830K | +11% |
| Equity | EUR 550K | +28% |
| Employees | 29 | — |
Legal name
Terapiamerkurius Oy
Y-tunnus number
2519458-5
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
20. joulukuuta 2012
Share capital
EUR 2 500
Employees
29 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on puheterapia ja muut terveys- ja sosiaalipalvelut. Yhtiö voi omistaa ja hallita kiinteistöjä sekä arvopapereita ja kädyä niillä kauppaa.
Address
Puntalantie 2
Phone
+3580401291004
Email
toimisto@terapiamerkurius.com
Website
www.terapiakeskuspuro.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 254 | 1 973 | 2 084 | 2 283 | 2 252 |
| Staff expenses | −894 | −1 312 | −1 349 | −1 631 | −1 524 |
| EBITDA | 116 | 147 | 216 | 103 | 210 |
| Depreciation & amort. | −15 | −16 | −18 | −24 | −21 |
| EBIT | 101 | 130 | 198 | 79 | 188 |
| Net financials | −0 | −0 | −0 | −0 | 5 |
| Profit before tax | 101 | 130 | 198 | 79 | 194 |
| Tax | 20 | 27 | 40 | 16 | 39 |
| Net profit | 81 | 104 | 158 | 63 | 155 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 394 | 548 | 725 | 746 | 830 |
| Equity | 171 | 262 | 399 | 430 | 550 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 223 | 286 | 327 | 316 | 280 |
| Total debt | 223 | 286 | 327 | 316 | 280 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20202024
Equity ratio
66.3%
This company
38.2%
Market median
+74% vs market
20202024
Return on equity
28.2%
This company
18.4%
Market median
+53% vs market
20202024
Net profit margin
6.9%
This company
8.1%
Market median
-15% vs market
20202024
Asset turnover
2.71×
This company
1.12×
Market median
+142% vs market
20202024
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RE Chief Executive Officer | Chief Executive Officer | 2013 |
AP Deputy Member | Deputy Member | 2013 |
| Former (2) | ||
HS | Audit | 2021 – 2023 |
JH | Audit | 2013 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Terapiamerkurius Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Riikka Elisa Brunou | Chief Executive Officer | 0 companies |
| Hanne Susanna Larinen | Audit | 0 companies |
| Jaakko Hermanni Luumi | Audit | 0 companies |
| Antti Pentti Einari Taskinen | Deputy Member | 0 companies |
| Päivi Marjatta Turkki | Board of Directors | 0 companies |